TNF and diabetic kidney disease: In the context of diabetic nephropathy, enalapril inhibited the TNF-α mRNA expression in the renal cortex and decreased both the renal and urinary TNF-α concentrations, correlating with reduced albuminuria and suggesting a protective effect against inflammation-induced renal damage [2,69].